Epidermal growth factor family receptors and inhibitors: radiation response modulators.
about
Prognostic impact of epidermal growth factor receptor (EGFR) expression on loco-regional recurrence after preoperative radiotherapy in rectal cancer.Radiosensitization of epidermal growth factor receptor/HER2-positive pancreatic cancer is mediated by inhibition of Akt independent of ras mutational status.Lapatinib in combination with radiation diminishes tumor regrowth in HER2+ and basal-like/EGFR+ breast tumor xenografts.The novel chemical entity YTR107 inhibits recruitment of nucleophosmin to sites of DNA damage, suppressing repair of DNA double-strand breaks and enhancing radiosensitizationRadiosensitivity in HeLa cervical cancer cells overexpressing glutathione S-transferase π 1The chemopreventive agent curcumin is a potent radiosensitizer of human cervical tumor cells via increased reactive oxygen species production and overactivation of the mitogen-activated protein kinase pathway.Efficacy and mechanism of action of the tyrosine kinase inhibitors gefitinib, lapatinib and neratinib in the treatment of HER2-positive breast cancer: preclinical and clinical evidencePhase I study and biomarker analysis of lapatinib and concurrent radiation for locally advanced breast cancer.Molecular interactions of ErbB1 (EGFR) and integrin-β1 in astrocytoma frozen sections predict clinical outcome and correlate with Akt-mediated in vitro radioresistance.Stress-Induced EGFR Trafficking: Mechanisms, Functions, and Therapeutic Implications.Young age is associated with ipsilateral breast tumor recurrence after breast conserving surgery and radiation therapy in patients with HER2-positive/ER-negative subtype.Reduction of nitric oxide level enhances the radiosensitivity of hypoxic non-small cell lung cancer.Locoregional recurrence and survival outcomes by type of local therapy and trastuzumab use among women with node-negative, HER2-positive breast cancer.Role of HER2 status in the treatment for brain metastases arising from breast cancer with stereotactic radiosurgery.
P2860
Q24812583-2AEBE18A-A942-4FD1-A65B-45FD7EA0F373Q33638654-B542EAD7-D99E-4730-94FC-2D0C9C4A2828Q34291564-265B4637-3744-4F6D-9041-C08C74CED74CQ35376477-B693CA8F-90CB-468A-8924-2FD3DAE24248Q35943285-CC1F6BA4-AF77-4EE1-A5E3-5D5BB2118E1CQ36104835-F79CD706-BA49-40BF-AFC0-68AFA35A06CCQ36250585-AC27E624-93D0-4EDE-8EC3-71FC1D5C8C4DQ36483151-2B90D111-3A97-47FA-BAE9-E939788DAABDQ37021563-06FE1F0C-815F-4423-9A35-B474137F41EDQ37432540-C4ABBAE3-354C-4A79-898B-1CB511F39B47Q38471204-77A3E1C3-941D-4730-A73C-44B72B726234Q39478026-28DFD374-D9D2-4DED-94BA-2F9FE86DA2EFQ44312876-64698B9D-0D84-4954-8649-62478A87D5BBQ54386567-E6BC9E5A-F68B-4A18-A514-E122A4210275
P2860
Epidermal growth factor family receptors and inhibitors: radiation response modulators.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Epidermal growth factor family receptors and inhibitors: radiation response modulators.
@en
type
label
Epidermal growth factor family receptors and inhibitors: radiation response modulators.
@en
prefLabel
Epidermal growth factor family receptors and inhibitors: radiation response modulators.
@en
P356
P1476
Epidermal growth factor family receptors and inhibitors: radiation response modulators.
@en
P2093
Carolyn I Sartor
P356
10.1053/SRAO.2003.50003
P577
2003-01-01T00:00:00Z